Management of adult male hypogonadism
| dc.contributor.author | Fasanmade, O.A. | |
| dc.date.accessioned | 2023-05-04T12:01:42Z | |
| dc.date.available | 2023-05-04T12:01:42Z | |
| dc.date.issued | 2023-03-24 | |
| dc.description | Presentation at the Lagos EMSON quarterly congress, 2023. | |
| dc.description.abstract | Adult male hypogonadism is a common condition worldwide. Its prevalence increses from 2.1% in middle aged men to 38.7% in elderly males. There are 2 main types hypergonadotrophic and hypogonadotrophic hypogonadism based on the level of the gonadotrophins (FSH and LH). Hypogonadotrophic type could be due to congenital, acquired causes or due to complications of systemic diseaes like diabetes mellitus, renal or hepatic failure. Most hypogonadotrophic hypogonadism cases present with low libido and poor erections. There are other metabolic derangements that accompany it. The main stay of this type of hypogonadism is testosterone replacement therapy.There are other treatment options such as use of selective estrogen receptor modulators, DHEAs amongst others | |
| dc.identifier.citation | Fasanmade OA. Management of adult male hypogonadism. Presentation at the Lagos EMSON quarterly congress, 2023. | |
| dc.identifier.uri | https://ir.unilag.edu.ng/handle/123456789/12335 | |
| dc.language.iso | en | |
| dc.publisher | Endocrinology and metabolism society of Nigeria | |
| dc.title | Management of adult male hypogonadism | |
| dc.type | Presentation |